← Back to Search

Other

Alexandrite Laser for Acne Scars

N/A
Waitlist Available
Research Sponsored by Cynosure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
A healthy male or female 18 - 65 years of age.
Healthy male or female aged 18-65
Must not have
Has an active localized or systemic infection, or an open wound in area being treated
Takes medication which is known to increase sensitivity to sunlight
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 day follow up
Awards & highlights
No Placebo-Only Group

Summary

This trial tested a laser device to treat acne scars on darker skin tones. Results showed it was safe and effective.

Who is the study for?
This trial is for healthy adults aged 18-65 with skin types V or VI who have acne scars on their face. Participants must not have had recent unprotected sun exposure, a history of keloid formation, immune disorders, coagulation issues, or be pregnant. They should agree to avoid other facial treatments and attend all study visits.
What is being tested?
The trial is testing the safety and effectiveness of an Alexandrite laser device in treating acne scars on darker skin tones (types V and VI). The goal is to see how well it works and monitor any side effects during treatment.
What are the potential side effects?
Potential side effects may include changes in skin pigmentation, discomfort at the treatment site, swelling, redness, blistering or potential scarring. There might also be risks related to light sensitivity or triggering pre-existing conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old and in good health.
Select...
I am between 18 and 65 years old and in good health.
Select...
I have had skin cancer or suspicious skin lesions in the area to be treated.
Select...
I am on medication that affects how my wounds heal.
Select...
I have not been exposed to the sun without protection or used tanning products in the last 4 weeks.
Select...
I have a blood clotting disorder or I'm on blood thinners, including high-dose aspirin.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have an infection or an open wound in the area that needs treatment.
Select...
I take medication that makes my skin more sensitive to sunlight.
Select...
I have moles that could turn into skin cancer.
Select...
I have a serious illness like lupus.
Select...
I have been treated with gold therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 day follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 day follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Photographic Evaluation of Changes in Treatment Areas
Secondary study objectives
Blinded evaluation of pre-treatment images vs. follow up images to determine which image is which
Photographic Evaluation of Treatment Areas
Principle Investigator assessment using the Global Aesthetic Improvement Scale (PGAIS)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Alexandrite LaserExperimental Treatment1 Intervention
Single arm, self-controlled

Find a Location

Who is running the clinical trial?

Cynosure, Inc.Lead Sponsor
51 Previous Clinical Trials
1,197 Total Patients Enrolled
6 Trials studying Acne Scars
173 Patients Enrolled for Acne Scars
Jennifer CiviokStudy DirectorCynosure, Inc.
16 Previous Clinical Trials
453 Total Patients Enrolled
3 Trials studying Acne Scars
112 Patients Enrolled for Acne Scars

Media Library

RF Device Arm (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04807179 — N/A
Acne Scars Research Study Groups: Alexandrite Laser
Acne Scars Clinical Trial 2023: RF Device Arm Highlights & Side Effects. Trial Name: NCT04807179 — N/A
RF Device Arm (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04807179 — N/A
Acne Scars Patient Testimony for trial: Trial Name: NCT04807179 — N/A
~8 spots leftby Dec 2025